Advertisement

Radiofrequency ablation of intrahepatic cholangiocarcinoma: feasability, local tumor control, and long-term outcome

  • Selim R. Butros
    Correspondence
    Corresponding author. Massachusetts General Hospital, Department of Radiology, Division of Abdominal Imaging and Intervention, 55 Fruit Street, Boston, MA 02114 USA. Tel.: +1 617 726 8354; fax: +1 617 726 4891.
    Affiliations
    Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St., White 270, Boston, MA 02114, USA
    Search for articles by this author
  • Anuradha Shenoy-Bhangle
    Affiliations
    Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St., White 270, Boston, MA 02114, USA
    Search for articles by this author
  • Peter R. Mueller
    Affiliations
    Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St., White 270, Boston, MA 02114, USA
    Search for articles by this author
  • Ronald S. Arellano
    Affiliations
    Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St., White 270, Boston, MA 02114, USA
    Search for articles by this author
Published:February 10, 2014DOI:https://doi.org/10.1016/j.clinimag.2014.01.013

      Abstract

      A retrospective analysis of patients who underwent radiofrequency ablation (RFA) of intrahepatic cholangiocarcinoma (IHCC) was performed. Seven patients with 9 tumors underwent RFA. The mean tumor size was 2.4 cm (range=1.3–3.3 cm). RFA achieved technique effectiveness and local tumor control in 89% (8/9 tumors) of the patients respectively, with a mean overall survival of 38.5 months (range=12–69 months). To conclude, RFA was effective in achieving local tumor control and may offer a therapeutic option for patients with recurrent or primary IHCC.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Yang J
        • Yan LN
        Current status of intrahepatic cholangiocarcinoma.
        World J Gastroenterol. 2008; 14: 6287-6289
        • Anderson CD
        • Pinson OW
        • Berlin J
        • Chari RS
        Diagnosis and treatment of cholangiocarcinoma.
        Oncologist. 2004; 9: 43-57
        • Puhalla H
        • Schuell B
        • Pokorny H
        • Kornek GV
        • Scheithauer W
        • Gruenberger T
        Treatment and outcome of intrahepatic cholangiocellular carcinoma.
        Am J Surg. 2005; 189: 173-177
        • Patel T
        Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.
        Hepatology. 2001; 33: 1353-1357
        • Shaib YH
        • El-Serag HB
        The epidemiology of cholangio-carcinoma.
        Semin Liver Dis. 2005; 24: 115-125
        • Taylor-Robinson SD
        • Toledano MB
        • Arora S
        • Keegan TJ
        • Hargreaves S
        • Beck A
        • Khan SA
        • Elliott P
        • Thomas HC
        Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998.
        Gut. 2001; 48: 816-820
        • Endo I
        • Gonen M
        • Yopp AC
        • Dalal KM
        • Zhou Q
        • Klimstra D
        • D’Angelica M
        • DeMatteo RP
        • Fong Y
        • Schwartz L
        • Kemeny N
        • O'Reilly E
        • Abou-Alfa GK
        • Shimada H
        • Blumgart LH
        • Jarnagin WR
        Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.
        Ann Surg. 2008; 248: 84-96
        • Yedibela S
        • Demir R
        • Zhang W
        • Meyer T
        • Hohenberger W
        • Schonleben F
        Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
        Ann Surg Oncol. 2009; 16: 404-412
        • Lin SM
        Recent advances in radiofrequency ablation in the treatment of hepatocellular carcinoma and metastatic liver cancers.
        Chang Gung Med J. 2009; 32: 22-32
        • Lau WY
        • Lai ECH
        The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review.
        Ann Surg. 2009; 249: 20-25
        • Sutherland LM
        • Williams JA
        • Padbury RT
        • Gotley DC
        • Stokes B
        • Maddern GJ
        Radiofrequency ablation of liver tumors: a systematic review.
        Arch Surg. 2006; 141: 181-190
        • Buscarini L
        • Buscarini E
        • Di Stasi M
        • Di Stasi M
        • Vallisa D
        • Quaretti P
        • Rocca A
        Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results.
        Eur Radiol. 2001; 11: 914-921
        • Machi J
        • Bueno RS
        • Wong LL
        Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma.
        World J Surg. 2005; 29: 1364-1373
        • Mazzaferro V
        • Battiston C
        • Perrone S
        • Pulvirenti A
        • Regalia E
        • Romito R
        • Sarli D
        • Schiavo M
        • Garbagnati F
        • Marchianò A
        • Spreafico C
        • Camerini T
        • Mariani L
        • Miceli R
        • Andreola S
        Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study.
        Ann Surg. 2004; 240: 900-909
        • Livraghi T
        • Meloni F
        • Di Stasi M
        • Rolle E
        • Solbiati L
        • Tinelli C
        • Rossi S
        Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice?.
        Hepatology. 2004; 47: 82-89
        • Sacks D
        • McClenny TE
        • Cardella JF
        • Lewis CA
        Society of Interventional Radiology clinical practice guidelines.
        J Vasc Interv Radiol. 2003; 14: 199-202
        • Goldberg SN
        • Grassi CJ
        • Cardella JF
        • Charboneau JW
        • Dodd GD
        • Dupuy DE
        • Gervais DA
        • Gillams AR
        • Kane RA
        • Lee FT
        • Livraghi T
        • McGahan J
        • Phillips DA
        • Rhim H
        • Silverman SG
        • Solbiati L
        • Vogl TJ
        • Wood BJ
        • Vedantham S
        • Sacks D
        Image-guided tumor ablation: standardization of terminology and reporting criteria.
        J Vasc Interv Radiol. 2009; 20: 377-390
        • Valle JW
        • Wasan H
        • Palmer DH
        • Cunningham D
        • Anthoney A
        • Maraveyas A
        • Madhusudan S
        • Iveson T
        • Hughes S
        • Pereira SP
        • Roughton M
        • Bridgewater J
        Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.
        N Engl J Med. 2010; 362: 1273-1281
        • Chu KM
        • Lai EC
        • Al-Hadeedi S
        • Arcilla CE
        • Lo CM
        • Liu CL
        • Fan ST
        • Wong J
        Intrahepatic cholangiocarcinoma.
        World J Surg. 1997; 21: 301-306
        • Kim JH
        • Won HJ
        • Shin YM
        • Kim PN
        • Lee SG
        • Hwang S
        Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection.
        Eur J Radiol. 2011; 80: 221-225
        • Carrafiello G
        • Lagana D
        • Cotta E
        • Mangini M
        • Fontana F
        • Bandiera F
        • Fugazzola C
        Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience.
        Cardiovasc Intervent Radiol. 2010; 33: 835-839
        • Chiou YY
        • Hwang JI
        • Chou YH
        • Wang HK
        • Chiang JH
        • Chang CY
        Percutaneous ultrasound guided radiofrequency ablation of intrahepatic cholangiocarcinoma.
        Kaohsiung J Med Sci. 2005; 21: 304-309
        • Kim JH
        • Won HJ
        • Shin YM
        • Kim KA
        • Kim PN
        Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma.
        AJR Am J Roentgenol. 2011; 196: 205-209
        • Fu Y
        • Yang W
        • Wu W
        • Yan K
        • Xing BC
        • Chen MH
        Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma.
        J Vasc Interv Radiol. 2012; 23: 642-649